Publications:

Predictive mutation signature of immunotherapy benefits in NSCLC based on machine learning algorithms.

Frontiers In Immunology

Liu, Zhichao Z; Lin, Guo G; Yan, Zeping Z; Li, Linduo L; Wu, Xingchen X; Shi, Jingrong J; He, Jianxing J; Zhao, Lei L; Liang, Hengrui H; Wang, Wei W

Publication Date: 2022

Variant appearance in text: ALK: 148C>T; Q50*

PubMed Link: 36238300

Variant Present in the following documents:

• Table_1.xlsx, sheet 4

View BVdb publication page

EPHA5 mutation was associated with adverse outcome of atezolizumab treatment in late-stage non-small cell lung cancers.

Bmc Pulmonary Medicine

Li, Zhenxiang Z; Zhou, Qing Q; Wang, Qi Q; Wang, Haiyong H; Yue, Weiming W

Publication Date: 2022-09-19

Variant appearance in text: ALK: 148C>T; Q50*

PubMed Link: 36123678

Variant Present in the following documents:

• 12890_2022_2161_MOESM2_ESM.xlsx, sheet 1

View BVdb publication page

MiRNA therapeutics based on logic circuits of biological pathways.

Bmc Bioinformatics

Boscaino, Valeria V; Fiannaca, Antonino A; La Paglia, Laura L; La Rosa, Massimo M; Rizzo, Riccardo R; Urso, Alfonso A

Publication Date: 2019-11-22

Variant appearance in text: ALK: 148C>T; Gln50Ter

PubMed Link: 31757209

Variant Present in the following documents:

• Main text
• 12859_2019_Article_2881.pdf

View BVdb publication page